Le LÚzard
Classified in: Health, Science and technology

22nd Century Group (Nasdaq: XXII) Expands VLN« Distributor Network with the Addition of Specialty Distributor Creager Mercantile

BUFFALO, N.Y., Oct. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company has added Creager Mercantile as a distribution partner to expand availability and support for its VLN« reduced nicotine content cigarette products in the state of Colorado.

Operating since 1958, Creager is a well-known wholesale supplier foráa wide array of cigarette retailers including hospital gift shops, gas stations, and tobacco shops across the state. The company supports more thaná1,000ástores across numerous specialty and retail store brands. Combined with 22nd Century's previously announced partnership with Eagle Rock Distributing Company, the Company now has access to thousands of potential retail sites across the state that could be serviced by its VLN« distribution partners.

22nd Century Group's proprietary VLN« cigarettes smoke, smell, and taste like a cigarette but contain approximately 95% less nicotine than conventional cigarettes, a level shown to be non-addictive. As noted on the packaging, VLN« is the only cigarette in the world purposefully designed to "Help You Smoke Less."

"We are excited to work with 22nd Century Group to make VLN« available to adult smokers in Colorado who are looking for a new way to cut their ties to nicotine," said Chip Creager, President of Creager Mercantile. "Creager supports a diverse array of specialty stores, often advising retailers on the best new products to add to their shelves. We believe that VLN«'s uniqueness as the first and only cigarette designed specifically to help smokers smoke less makes it an important and attractive product for adult smokers, and we will be actively working with our retail partners to launch VLN« to their stores in the coming months."

"Creager opens up an entire additional channel of specialty retail and tobacco suppliers across the state of Colorado, and its direct role in product recommendations and store support make it an ideal partner for 22nd Century's VLN« rollout," said John J. Miller, president of 22nd Century's Tobacco Business. "We look forward to working directly with Creager to place VLN« on as many shelves as possible, making our important new product broadly available in as many locations as possible where traditional combustible cigarettes are sold."

More information about Creager can be found online at https://creagermerc.com/.

22nd Century Group's decision to launch in Colorado follows the exceptional pilot results in Chicago and the Company's plans to have distribution and retail partnerships in place to support the expanding availability of VLN« to adult smokers across the country. The Chicago pilot demonstrated that in-store outreach was highly effective, and once adult smokers had tried VLN«, the vast majority were quick to recommend VLN« to other adult smokers. Specialty distribution such as Creager, which supports additional functions such as merchandising and product advice, expands the awareness of VLN«'s highly differentiated value proposition in key retail channels.

About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq:áXXII) is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of theáFDA's Comprehensive Planáto address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

Learn more atáxxiicentury.com, on Twitter, onáLinkedIn, and on YouTube.

Learn more about VLN«áatátryvln.com.

Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 1, 2022, and in the Company's Quarterly Report filed on August 9, 2022. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact
Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations

Darrow Associates Investor Relations
Matt Kreps
T: 214-597-8200

These press releases may also interest you

at 10:00
Ontario's colleges have launched new upgrading courses for internationally educated nurses that could allow some nurses to attain the qualifications to work in Ontario within four to six months. "Colleges are playing a prominent role in strengthening...

at 10:00
Cell & Gene Therapy Manufacturing Services Marketáis projected to reach USD 11.5 billion by 2027 from USD 5.1 billion in 2022, at a CAGR of 17.5% during the forecast period, according to a new report by MarketsandMarketstm. Growth in this market is...

at 10:00
Hospital for Special Surgery (HSS) today announced that Bryan T. Kelly, MD, MBA will succeed President and Chief Executive Officer Louis A. Shapiro in a phased transition over the course of 2023, becoming the first surgeon to lead the 160-year-old...

at 10:00
As Brain Power Wellness reviews the passing of another successful year, the holistic wellness organization highlights how it ended 2022 by hosting a staff retreat in Nicaragua. This retreat was a positive milestone for...

at 09:48
The U.S. Food and Drug Administration today announced it is proposing a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV....

at 09:05
Know Labs, Inc. , an emerging developer of non-invasive medical diagnostic technology, today announced changes to its executive leadership team. The new structure will help the Company accelerate the development and delivery of its non-invasive...

News published on 3 october 2022 at 09:25 and distributed by: